{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,7]],"date-time":"2026-02-07T08:17:49Z","timestamp":1770452269727,"version":"3.49.0"},"reference-count":43,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2019,4,1]],"date-time":"2019-04-01T00:00:00Z","timestamp":1554076800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100004271","name":"Sapienza University of Rome","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004271","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100009880","name":"Regione Lazio","doi-asserted-by":"publisher","award":["85-2017-13763"],"award-info":[{"award-number":["85-2017-13763"]}],"id":[{"id":"10.13039\/501100009880","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004588","name":"Pasteur Institute-Cenci Bolognetti Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004588","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Antimicrobial Agents"],"published-print":{"date-parts":[[2019,4]]},"DOI":"10.1016\/j.ijantimicag.2018.11.008","type":"journal-article","created":{"date-parts":[[2018,11,23]],"date-time":"2018-11-23T05:55:08Z","timestamp":1542952508000},"page":"449-455","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"title":["The antimetabolite 3-bromopyruvate selectively inhibits Staphylococcus aureus"],"prefix":"10.1016","volume":"53","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6128-7039","authenticated-orcid":false,"given":"Paolo","family":"Visca","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Federica","family":"Pisa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5080-5665","authenticated-orcid":false,"given":"Francesco","family":"Imperi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijantimicag.2018.11.008_bib0001","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1038\/nrd3776","article-title":"Drug repurposing programmes get lift off","volume":"11","author":"Mullard","year":"2012","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.ijantimicag.2018.11.008_bib0002","doi-asserted-by":"crossref","first-page":"282","DOI":"10.3389\/fmicb.2015.00282","article-title":"Drug repurposing as an alternative for the treatment of recalcitrant bacterial infections","volume":"6","author":"Rangel-Vega","year":"2015","journal-title":"Front Microbiol"},{"key":"10.1016\/j.ijantimicag.2018.11.008_bib0003","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1042\/ETLS20160018","article-title":"Drug repurposing for antivirulence therapy against opportunistic bacterial pathogens","volume":"1","author":"Rampioni","year":"2017","journal-title":"Emerg Top Life Sci"},{"key":"10.1016\/j.ijantimicag.2018.11.008_bib0004","first-page":"3909","article-title":"Novel therapy for liver cancer: direct intraarterial injection of a potent inhibitor of ATP production","volume":"62","author":"Geschwind","year":"2002","journal-title":"Cancer Res"},{"key":"10.1016\/j.ijantimicag.2018.11.008_bib0005","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1007\/s10863-012-9422-7","article-title":"Targeting aerobic glycolysis: 3-bromopyruvate as a promising anticancer drug","volume":"44","author":"Cardaci","year":"2012","journal-title":"J Bioenerg Biomembr"},{"key":"10.1016\/j.ijantimicag.2018.11.008_bib0006","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1007\/s10863-016-9670-z","article-title":"The anticancer agent 3-bromopyruvate: a simple but powerful molecule taken from the lab to the bedside","volume":"48","author":"Azevedo-Silva","year":"2016","journal-title":"J Bioenerg Biomembr"},{"key":"10.1016\/j.ijantimicag.2018.11.008_bib0007","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1007\/s11033-014-3764-7","article-title":"The Warburg effect: molecular aspects and therapeutic possibilities","volume":"42","author":"Ngo","year":"2015","journal-title":"Mol Biol Rep"},{"key":"10.1016\/j.ijantimicag.2018.11.008_bib0008","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1007\/s10863-012-9417-4","article-title":"A translational study \u2018case report\u2019 on the small molecule \u2018energy blocker\u2019 3-bromopyruvate (3BP) as a potent anticancer agent: from bench side to bedside","volume":"44","author":"Ko","year":"2012","journal-title":"J Bioenerg Biomembr"},{"key":"10.1016\/j.ijantimicag.2018.11.008_bib0009","first-page":"356","article-title":"Safety and outcome of treatment of metastatic melanoma using 3-bromopyruvate: a concise literature review and case study","volume":"33","author":"El Sayed","year":"2014","journal-title":"Chin J Cancer"},{"key":"10.1016\/j.ijantimicag.2018.11.008_bib0010","article-title":"Candidate cancer drug suspected after death of three patients at an alternative medicine clinic","volume":"12","author":"Feldwisch-Drentrup","year":"2016","journal-title":"Science"},{"key":"10.1016\/j.ijantimicag.2018.11.008_bib0011","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1016\/j.bbrc.2013.02.125","article-title":"3-Bromopyruvate: a novel antifungal agent against the human pathogen Cryptococcus neoformans","volume":"434","author":"Dyl\u0105g","year":"2013","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.ijantimicag.2018.11.008_bib0012","doi-asserted-by":"crossref","first-page":"375","DOI":"10.3389\/fphar.2018.00375","article-title":"3-Bromopyruvate as an alternative option for the treatment of protothecosis","volume":"9","author":"Jagielski","year":"2018","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.ijantimicag.2018.11.008_bib0013","unstructured":"Geschwind JF, Vali M. Methods of treatment using 3-bromopyruvate and other selective inhibitors of ATP production. Patent WO2011127200A2. October 13, 2011."},{"key":"10.1016\/j.ijantimicag.2018.11.008_bib0014","doi-asserted-by":"crossref","first-page":"16131","DOI":"10.1038\/srep16131","article-title":"The Mycobacterium tuberculosis H37Ra gene MRA_1916 causes growth defects upon down-regulation","volume":"5","author":"Singh","year":"2015","journal-title":"Sci Rep"},{"key":"10.1016\/j.ijantimicag.2018.11.008_bib0015","doi-asserted-by":"crossref","first-page":"725","DOI":"10.2217\/fmb.14.33","article-title":"Evaluation of different microtiter plate-based methods for the quantitative assessment of Staphylococcus aureus biofilms","volume":"9","author":"Elkhatib","year":"2014","journal-title":"Future Microbiol"},{"key":"10.1016\/j.ijantimicag.2018.11.008_bib0016","series-title":"Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically; approved standard","year":"2012"},{"key":"10.1016\/j.ijantimicag.2018.11.008_bib0017","series-title":"Methods for determining bactericidal activity of antimicrobial agents; approved guideline","year":"1999"},{"key":"10.1016\/j.ijantimicag.2018.11.008_bib0018","doi-asserted-by":"crossref","first-page":"1914","DOI":"10.1128\/AAC.40.8.1914","article-title":"Comparison of three different in vitro methods of detecting synergy: time-kill, checkerboard, and E test","volume":"40","author":"White","year":"1996","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2018.11.008_bib0019","doi-asserted-by":"crossref","first-page":"17593","DOI":"10.1038\/srep17593","article-title":"In vitro and in vivo screening for novel essential cell-envelope proteins in Pseudomonas aeruginosa","volume":"5","author":"Fern\u00e1ndez-Pi\u00f1ar","year":"2015","journal-title":"Sci Rep"},{"key":"10.1016\/j.ijantimicag.2018.11.008_bib0020","doi-asserted-by":"crossref","first-page":"4178","DOI":"10.1128\/AAC.01301-09","article-title":"An ertapenem-resistant extended-spectrum-beta-lactamase-producing Klebsiella pneumoniae clone carries a novel OmpK36 porin variant","volume":"54","author":"Garc\u00eda-Fern\u00e1ndez","year":"2010","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2018.11.008_bib0021","doi-asserted-by":"crossref","first-page":"2616","DOI":"10.1128\/AAC.01643-07","article-title":"Whole-genome pyrosequencing of an epidemic multidrug-resistant Acinetobacter baumannii strain belonging to the European clone II group","volume":"52","author":"Iacono","year":"2008","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2018.11.008_bib0022","doi-asserted-by":"crossref","first-page":"5641","DOI":"10.1128\/AAC.01097-15","article-title":"Pyoverdine and proteases affect the response of Pseudomonas aeruginosa to gallium in human serum","volume":"59","author":"Bonchi","year":"2015","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2018.11.008_bib0023","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/j.bbrc.2014.08.066","article-title":"The antitumor agent 3-bromopyruvate has a short half-life at physiological conditions","volume":"452","author":"Glick","year":"2014","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.ijantimicag.2018.11.008_bib0024","doi-asserted-by":"crossref","first-page":"4275","DOI":"10.1128\/JB.00081-07","article-title":"Anaerobic gene expression in Staphylococcus aureus","volume":"189","author":"Fuchs","year":"2007","journal-title":"J Bacteriol"},{"key":"10.1016\/j.ijantimicag.2018.11.008_bib0025","doi-asserted-by":"crossref","first-page":"e58277","DOI":"10.1371\/journal.pone.0058277","article-title":"Effect of oxygen on glucose metabolism: utilization of lactate in Staphylococcus aureus as revealed by in vivo NMR studies","volume":"8","author":"Ferreira","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.ijantimicag.2018.11.008_bib0026","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1046\/j.1469-0691.2000.00149.x","article-title":"EUCAST Definitive Document E.Def 1.2, May 2000: Terminology relating to methods for the determination of susceptibility of bacteria to antimicrobial agents","volume":"6","year":"2000","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.ijantimicag.2018.11.008_bib0027","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1093\/femsre\/fux010","article-title":"Molecular mechanisms of biofilm-based antibiotic resistance and tolerance in pathogenic bacteria","volume":"41","author":"Hall","year":"2017","journal-title":"FEMS Microbiol Rev"},{"key":"10.1016\/j.ijantimicag.2018.11.008_bib0028","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1158\/1940-6207.CAPR-11-0338","article-title":"Aerosolized 3-bromopyruvate inhibits lung tumorigenesis without causing liver toxicity","volume":"5","author":"Zhang","year":"2012","journal-title":"Cancer Prev Res"},{"key":"10.1016\/j.ijantimicag.2018.11.008_bib0029","first-page":"228","volume":"36","author":"Bouvet","year":"1986","journal-title":"Int J Syst Evol Microbiol"},{"key":"10.1016\/j.ijantimicag.2018.11.008_bib0030","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1007\/s10482-012-9704-4","article-title":"Identification and characterization of an indigo-producing oxygenase involved in indole 3-acetic acid utilization by Acinetobacter baumannii","volume":"101","author":"Lin","year":"2012","journal-title":"Antonie Van Leeuwenhoek"},{"key":"10.1016\/j.ijantimicag.2018.11.008_bib0031","first-page":"1521","article-title":"Glycollate inhibition of growth of Pseudomonas aeruginosa on lactate medium","volume":"133","author":"Brown","year":"1987","journal-title":"J Gen Microbiol"},{"key":"10.1016\/j.ijantimicag.2018.11.008_bib0032","doi-asserted-by":"crossref","first-page":"4596","DOI":"10.1128\/JB.186.14.4596-4604.2004","article-title":"Long-term anaerobic survival of the opportunistic pathogen Pseudomonas aeruginosa via pyruvate fermentation","volume":"186","author":"Eschbach","year":"2004","journal-title":"J Bacteriol"},{"key":"10.1016\/j.ijantimicag.2018.11.008_bib0033","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1038\/nrmicro1932","article-title":"Carbon catabolite repression in bacteria: many ways to make the most out of nutrients","volume":"6","author":"G\u00f6rke","year":"2008","journal-title":"Nat Rev Microbiol"},{"key":"10.1016\/j.ijantimicag.2018.11.008_bib0034","doi-asserted-by":"crossref","first-page":"e67125","DOI":"10.1371\/journal.pone.0067125","article-title":"Characterization of pyruvate uptake in Escherichia coli K-12","volume":"8","author":"Kreth","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.ijantimicag.2018.11.008_bib0035","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1007\/s10541-005-0248-3","article-title":"Glutathione in bacteria","volume":"70","author":"Smirnova","year":"2005","journal-title":"Biochemistry (Mosc)"},{"key":"10.1016\/j.ijantimicag.2018.11.008_bib0036","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1089\/ars.2006.8.753","article-title":"The many faces of glutathione in bacteria","volume":"8","author":"Masip","year":"2006","journal-title":"Antioxid Redox Signal"},{"key":"10.1016\/j.ijantimicag.2018.11.008_bib0037","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1016\/j.bbrc.2010.04.126","article-title":"3-Bromopyruvate induces necrotic cell death in sensitive melanoma cell lines","volume":"396","author":"Qin","year":"2010","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.ijantimicag.2018.11.008_bib0038","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.mehy.2017.01.014","article-title":"The promising anticancer drug 3-bromopyruvate is metabolized through glutathione conjugation which affects chemoresistance and clinical practice: an evidence-based view","volume":"100","author":"El Sayed","year":"2017","journal-title":"Med Hypotheses"},{"key":"10.1016\/j.ijantimicag.2018.11.008_bib0039","doi-asserted-by":"crossref","DOI":"10.1128\/mSphere.00155-18","article-title":"Pseudomonas aeruginosa gshA mutant is defective in biofilm formation, swarming, and pyocyanin production","volume":"3","author":"Van Laar","year":"2018","journal-title":"mSphere"},{"key":"10.1016\/j.ijantimicag.2018.11.008_bib0040","first-page":"107","article-title":"Multidrug tolerance of biofilms and persister cells","volume":"322","author":"Lewis","year":"2008","journal-title":"Curr Top Microbiol Immunol"},{"key":"10.1016\/j.ijantimicag.2018.11.008_bib0041","doi-asserted-by":"crossref","first-page":"3502","DOI":"10.1128\/AEM.65.8.3502-3511.1999","article-title":"Depth penetration and detection of pH gradients in biofilms by two-photon excitation microscopy","volume":"65","author":"Vroom","year":"1999","journal-title":"Appl Environ Microbiol"},{"key":"10.1016\/j.ijantimicag.2018.11.008_bib0042","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1007\/s12275-011-1013-5","article-title":"The activity of a small lytic peptide PTP-7 on Staphylococcus aureus biofilms","volume":"49","author":"Kharidia","year":"2011","journal-title":"J Microbiol"},{"key":"10.1016\/j.ijantimicag.2018.11.008_bib0043","doi-asserted-by":"crossref","first-page":"445","DOI":"10.4161\/viru.2.5.17724","article-title":"Staphylococcus aureus biofilms: properties, regulation, and roles in human disease","volume":"2","author":"Archer","year":"2011","journal-title":"Virulence"}],"container-title":["International Journal of Antimicrobial Agents"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924857918303339?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924857918303339?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,11,15]],"date-time":"2020-11-15T20:47:39Z","timestamp":1605473259000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0924857918303339"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,4]]},"references-count":43,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2019,4]]}},"alternative-id":["S0924857918303339"],"URL":"https:\/\/doi.org\/10.1016\/j.ijantimicag.2018.11.008","relation":{},"ISSN":["0924-8579"],"issn-type":[{"value":"0924-8579","type":"print"}],"subject":[],"published":{"date-parts":[[2019,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The antimetabolite 3-bromopyruvate selectively inhibits Staphylococcus aureus","name":"articletitle","label":"Article Title"},{"value":"International Journal of Antimicrobial Agents","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijantimicag.2018.11.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier B.V. and International Society of Chemotherapy. All rights reserved.","name":"copyright","label":"Copyright"}]}}